From: Clinical and pathological staging of the cancer at the nanoscale
Tumor number | Number of cells | Percentage of labeled cells by [3H] tritiated thymidine | Amount of the used [14C] thymidine | Percentage of labeled cells by [14C] thymidine | Doubling time (h) |
---|---|---|---|---|---|
1 | 25,838 | 26.5 % |
| 75.67 % | 22 |
2 | 22,015 | 20.2 % |
| 69 % | 28 |
3 | 13,443 | 10.9 % |
| 43.31 % | 48 |
4 | 9,800 | 4.5 % |
| 16.65 % | 112 |
5 | 9,605 | 15.4 % |
| 24.67 % | 35 |